Abstract
It is well established that hypoxia is prevalent in human tumors and is associated with resistance to radiotherapy and chemotherapy ([1–3][1]); furthermore, hypoxia contributes to immune checkpoint activation ([4–7][2]), higher likelihood for development of metastasis, and worse overall
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
